School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, China.
Division of Biotechnology, Dalian Institute of Chemical Physics, Dalian, 116023, China.
Microb Cell Fact. 2019 Feb 2;18(1):27. doi: 10.1186/s12934-019-1077-1.
L-Alanyl-L-glutamine (Ala-Gln) represents the great application potential in clinic due to the unique physicochemical properties. A new approach was developed to synthesize Ala-Gln by recombinant Escherichia coli OPA, which could overcome the disadvantages of traditional chemical synthesis. Although satisfactory results had been obtained with recombinant E. coli OPA, endotoxin and the use of multiple antibiotics along with toxic inducer brought the potential biosafety hazard for the clinical application of Ala-Gln.
In this study, the safer host Pichia pastoris was applied as an alternative to E. coli. A recombinant P. pastoris (named GPA) with the original gene of α-amino acid ester acyltransferase (SsAet) from Sphingobacterium siyangensis SY1, was constructed to produce Ala-Gln. To improve the expression efficiency of SsAet in P. pastoris, codon optimization was conducted to obtain the strain GPAp. Here, we report that Ala-Gln production by GPAp was approximately 2.5-fold more than that of GPA. The optimal induction conditions (cultivated for 3 days at 26 °C with a daily 1.5% of methanol supplement), the optimum reaction conditions (28 °C and pH 8.5), and the suitable substrate conditions (AlaOMe/Gln = 1.5/1) were also achieved for GPAp. Although most of the metal ions had no effects, the catalytic activity of GPAp showed a slight decrease in the presence of Fe and an obvious increase when cysteine or PMSF were added. Under the optimum conditions, the Ala-Gln generation by GPAp realized the maximum molar yield of 63.5% and the catalytic activity of GPAp by agar embedding maintained extremely stable after 10 cycles.
Characterized by economy, efficiency and practicability, production of Ala-Gln by recycling immobilized GPAp (whole-cell biocatalyst) is represents a green and promising way in industrial.
由于独特的物理化学性质,L-丙氨酰-L-谷氨酰胺(Ala-Gln)在临床上具有巨大的应用潜力。通过重组大肠杆菌 OPA 开发了一种新的合成 Ala-Gln 的方法,该方法可以克服传统化学合成的缺点。尽管使用重组大肠杆菌 OPA 已经取得了令人满意的结果,但内毒素和多种抗生素的使用以及有毒诱导剂给 Ala-Gln 的临床应用带来了潜在的生物安全隐患。
在本研究中,应用更安全的宿主毕赤酵母替代大肠杆菌。构建了具有来自鞘氨醇单胞菌 SY1 的α-氨基酸酯酰基转移酶(SsAet)原始基因的重组毕赤酵母(命名为 GPA)来生产 Ala-Gln。为了提高 SsAet 在毕赤酵母中的表达效率,对其进行了密码子优化以获得菌株 GPAp。在这里,我们报告说,与 GPA 相比,GPAp 生产 Ala-Gln 的效率约提高了 2.5 倍。还确定了最佳诱导条件(在 26°C 下培养 3 天,每天补充 1.5%甲醇)、最佳反应条件(28°C 和 pH 8.5)和合适的底物条件(AlaOMe/Gln=1.5/1)。尽管大多数金属离子没有影响,但 GPAp 的催化活性在存在铁时略有下降,而在添加半胱氨酸或 PMSF 时则明显增加。在最佳条件下,GPAp 产生的 Ala-Gln 的摩尔产率达到了 63.5%的最大值,并且通过琼脂包埋固定化的 GPAp 的催化活性在 10 个循环后仍保持非常稳定。
利用循环固定化 GPAp(全细胞生物催化剂)生产 Ala-Gln 的方法具有经济、高效和实用的特点,是一种绿色、有前途的工业生产方法。